Rowe T, Fletcher A, Svoboda P, Pohl J, Hatta Y, Jasso G
NPJ Vaccines. 2024; 9(1):199.
PMID: 39448628
PMC: 11502657.
DOI: 10.1038/s41541-024-00973-2.
Hundakova A, Toman M, Knotek Z
Vet Med (Praha). 2024; 67(8):408-417.
PMID: 38716186
PMC: 11071139.
DOI: 10.17221/22/2021-VETMED.
Stander J, Mbewana S, Meyers A
BioDrugs. 2022; 36(5):573-589.
PMID: 35821564
PMC: 9275545.
DOI: 10.1007/s40259-022-00544-8.
Gallovic M, Junkins R, Sandor A, Pena E, Sample C, Mason A
J Control Release. 2022; 347:356-368.
PMID: 35569585
PMC: 10136936.
DOI: 10.1016/j.jconrel.2022.05.017.
Lopez-Gordo E, Orlowski A, Wang A, Weinberg A, Sahoo S, Weber T
Front Med (Lausanne). 2022; 8:732095.
PMID: 35036407
PMC: 8757481.
DOI: 10.3389/fmed.2021.732095.
Non-Mouse-Adapted H1N1pdm09 Virus as a Model for Influenza Research.
Kiseleva I, Rekstin A, Al Farroukh M, Bazhenova E, Katelnikova A, Puchkova L
Viruses. 2020; 12(6).
PMID: 32485821
PMC: 7354452.
DOI: 10.3390/v12060590.
Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity.
Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M
Science. 2020; 367(6480).
PMID: 32079747
PMC: 7432993.
DOI: 10.1126/science.aau0810.
Prime-pull vaccination with a plant-derived virus-like particle influenza vaccine elicits a broad immune response and protects aged mice from death and frailty after challenge.
Hodgins B, Pillet S, Landry N, Ward B
Immun Ageing. 2019; 16:27.
PMID: 31700523
PMC: 6829930.
DOI: 10.1186/s12979-019-0167-6.
Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
Korenkov D, Laurie K, Reading P, Carolan L, Chan K, Isakova-Sivak I
Infect Genet Evol. 2018; 64:95-104.
PMID: 29929009
PMC: 6330673.
DOI: 10.1016/j.meegid.2018.06.019.
Novel Platforms for the Development of a Universal Influenza Vaccine.
Kumar A, Sundebo Meldgaard T, Bertholet S
Front Immunol. 2018; 9:600.
PMID: 29628926
PMC: 5877485.
DOI: 10.3389/fimmu.2018.00600.
Effect of serial pig passages on the adaptation of an avian H9N2 influenza virus to swine.
Gracia J, Van den Hoecke S, Saelens X, Van Reeth K
PLoS One. 2017; 12(4):e0175267.
PMID: 28384328
PMC: 5383288.
DOI: 10.1371/journal.pone.0175267.
A Review of Analytical Techniques and Their Application in Disease Diagnosis in Breathomics and Salivaomics Research.
Beale D, Jones O, Karpe A, Dayalan S, Oh D, Kouremenos K
Int J Mol Sci. 2016; 18(1).
PMID: 28025547
PMC: 5297659.
DOI: 10.3390/ijms18010024.
Cornerstones of CRISPR-Cas in drug discovery and therapy.
Fellmann C, Gowen B, Lin P, Doudna J, Corn J
Nat Rev Drug Discov. 2016; 16(2):89-100.
PMID: 28008168
PMC: 5459481.
DOI: 10.1038/nrd.2016.238.
Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in Ferrets.
Pascua P, Marathe B, Burnham A, Vogel P, Webby R, Webster R
PLoS One. 2016; 11(7):e0159847.
PMID: 27466813
PMC: 4965113.
DOI: 10.1371/journal.pone.0159847.
A Review of Radiation-Induced Coagulopathy and New Findings to Support Potential Prevention Strategies and Treatments.
Kennedy A, Maity A, Sanzari J
Radiat Res. 2016; 186(2):121-40.
PMID: 27459701
PMC: 5041298.
DOI: 10.1667/RR14406.1.
Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus.
Music N, Reber A, Kim J, York I
PLoS One. 2016; 11(6):e0157903.
PMID: 27315117
PMC: 4912066.
DOI: 10.1371/journal.pone.0157903.
Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
Fullen D, Noulin N, Catchpole A, Fathi H, Murray E, Mann A
PLoS One. 2016; 11(1):e0145902.
PMID: 26761707
PMC: 4711822.
DOI: 10.1371/journal.pone.0145902.
Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets.
Music N, Reber A, Kim M, York I, Kang S
Vaccine. 2015; 34(4):466-473.
PMID: 26709639
PMC: 4713238.
DOI: 10.1016/j.vaccine.2015.12.023.
Modeling human influenza infection in the laboratory.
Radigan K, Misharin A, Chi M, Budinger G
Infect Drug Resist. 2015; 8:311-20.
PMID: 26357484
PMC: 4560508.
DOI: 10.2147/IDR.S58551.
Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus.
Wiley C, Bhardwaj N, Ross T, Bissel S
Brain Pathol. 2015; 25(5):634-50.
PMID: 26276027
PMC: 4538697.
DOI: 10.1111/bpa.12281.